Michael Tsoukas, M.D.

Trials

Studies that name Michael Tsoukas, M.D. as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:18 UTC. Open this list on ClinicalTrials.gov

• Ph1
  NCT06753994 · Continuous Ketone Monitoring in People With Type 1 Diabetes Using SGLT2 Inhibitors

  McGill University · completed · Diabetes, Type1diabetes, T1D · principal investigator
• Ph2/Ph3
  NCT06046417 · A Fully Automated Lyumjev and Pramlintide Delivery System for Adults With Type 1 Diabetes

  McGill University Health Centre/Research Institute of the McGill University Health Centre · unknown · type1diabetes, Diabetes Mellitus, Type 1 · principal investigator
• Ph2
  NCT06021158 · A Trial to Compare Automated Lyumjev Delivery With Carbohydrate Counting, Qualitative Meal-size Estimation, and Meal Detection in Type 1 Diabetes

  McGill University Health Centre/Research Institute of the McGill University Health Centre · unknown · Diabetes Mellitus, Type 1, Type 1 Diabetes · principal investigator
• N/A
  NCT05199714 · A Fully-closed Loop, Pramlintide and Insulin, Artificial Pancreas Clinical Trial for Adults With Type 1 Diabetes

  McGill University Health Centre/Research Institute of the McGill University Health Centre · completed · Type 1 Diabetes · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 07:18 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.